Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics


Sarepta Therapeutics, Inc. (SRPT): $71.14

-1.02 (-1.41%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SRPT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 491

in industry

SRPT Stock Summary

  • Price to trailing twelve month operating cash flow for SRPT is currently 53.33, higher than 90.98% of US stocks with positive operating cash flow.
  • Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 16.25% of US stocks have a lower such ratio.
  • Revenue growth over the past 12 months for Sarepta Therapeutics Inc comes in at 41.82%, a number that bests 87.98% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Sarepta Therapeutics Inc, a group of peers worth examining would be EDIT, STRO, ALPN, XLRN, and SRRK.
  • Visit SRPT's SEC page to see the company's official filings. To visit the company's web site, go to www.sarepta.com.

SRPT Stock Price Chart Interactive Chart >

Price chart for SRPT

SRPT Price/Volume Stats

Current price $71.14 52-week high $181.83
Prev. close $72.16 52-week low $68.04
Day low $70.70 Volume 630,016
Day high $73.34 Avg. volume 1,908,583
50-day MA $80.39 Dividend yield N/A
200-day MA $126.32 Market Cap 5.65B

Sarepta Therapeutics, Inc. (SRPT) Company Bio


Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.


SRPT Latest News Stream


Event/Time News Detail
Loading, please wait...

SRPT Latest Social Stream


Loading social stream, please wait...

View Full SRPT Social Stream

Latest SRPT News From Around the Web

Below are the latest news stories about Sarepta Therapeutics Inc that investors may wish to consider to help them evaluate SRPT as an investment opportunity.

RBC Capital Stick to Their Buy Rating for Sarepta Therapeutics By Investing.com

RBC Capital Stick to Their Buy Rating for Sarepta Therapeutics

Investing.com | April 11, 2021

Is SRPT Stock A Buy or Sell?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 887 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

Yahoo | April 7, 2021

Is Sarepta Therapeutics Worthy of Redemption?

A potentially misinterpreted clinical trial readout from January may mean a market opportunity for bargain hunters.

Yahoo | April 1, 2021

The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Veric...

Benzinga | March 19, 2021

Needham Stick to Their Buy Rating for Sarepta Therapeutics By Investing.com

Needham Stick to Their Buy Rating for Sarepta Therapeutics

Investing.com | March 19, 2021

Read More 'SRPT' Stories Here

SRPT Price Returns

1-mo -9.47%
3-mo -27.59%
6-mo -48.35%
1-year -37.78%
3-year -9.16%
5-year 375.85%
YTD -58.27%
2020 32.12%
2019 18.24%
2018 96.14%
2017 102.84%
2016 -28.90%

Continue Researching SRPT

Want to see what other sources are saying about Sarepta Therapeutics Inc's financials and stock price? Try the links below:

Sarepta Therapeutics Inc (SRPT) Stock Price | Nasdaq
Sarepta Therapeutics Inc (SRPT) Stock Quote, History and News - Yahoo Finance
Sarepta Therapeutics Inc (SRPT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.1009 seconds.